Pulmonary atresia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
 
(4 intermediate revisions by 2 users not shown)
Line 2: Line 2:
{{Xyz}}
{{Xyz}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} :{{mwaq}}
==Overview==
==Overview==


Line 10: Line 10:
*Overall, the estimated frequency of Pulmonary atresia among all congenital heart disease is 1-3 %  
*Overall, the estimated frequency of Pulmonary atresia among all congenital heart disease is 1-3 %  
*While there is no difference in the incidence of Pulmonary atresia in males or females, it is found that pulmonary atresia with VSD ( PA-VSD ) is slightly more prevalent in males compared to females.
*While there is no difference in the incidence of Pulmonary atresia in males or females, it is found that pulmonary atresia with VSD ( PA-VSD ) is slightly more prevalent in males compared to females.
===Prevalence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.


===Case-fatality rate/Mortality rate===
===Case-fatality rate/Mortality rate===
Line 21: Line 16:


===Age===
===Age===
*Patients of all age groups may develop [disease name].
*Pulmonary atresia is exclusively a congenital disease and is diagnosed either prenatally or immediately after birth.
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===
Line 31: Line 22:
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
===Gender===
===Gender===
*[Disease name] affects men and women equally.
*It is found that pulmonary atresia with VSD ( PA-VSD ) is slightly more prevalent in males compared to females.
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
 
===Region===
*The majority of [disease name] cases are reported in [geographical region].
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].


===Developed Countries===
===Developed Countries===

Latest revision as of 21:21, 14 July 2020

Xyz Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary atresia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pulmonary atresia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary atresia epidemiology and demographics

CDC on Pulmonary atresia epidemiology and demographics

Pulmonary atresia epidemiology and demographics in the news

Blogs on Pulmonary atresia epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Pulmonary atresia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  :Muhammad Waqas, M.D.[2]

Overview

Epidemiology and Demographics

Incidence

  • The incidence of Pulmonary atresia subtype Intact VSD is approximately 4-8 per 100,000 individuals worldwide.
  • Overall, the estimated frequency of Pulmonary atresia among all congenital heart disease is 1-3 %
  • While there is no difference in the incidence of Pulmonary atresia in males or females, it is found that pulmonary atresia with VSD ( PA-VSD ) is slightly more prevalent in males compared to females.

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • Pulmonary atresia is exclusively a congenital disease and is diagnosed either prenatally or immediately after birth.

Race

  • There is no racial predilection to [disease name].
  • [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

  • It is found that pulmonary atresia with VSD ( PA-VSD ) is slightly more prevalent in males compared to females.

Developed Countries

Developing Countries

References

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Pulmonary_atresia_epidemiology_and_demographics&oldid=1626826"